EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
DiaMedica Therapeutics, Inc. (DMAC) EBIT Margin data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-8.74M |
|
-- |
|
-- |
|
$9.21M |
|
$-9.21M |
|
$0.48M |
|
$-8.73M |
|
$-8.73M |
|
$-8.74M |
|
$-8.74M |
|
$-8.74M |
|
$-8.74M |
|
$-9.21M |
|
$-9.45M |
|
46.98M |
|
46.98M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$60.63M |
|
$0.14M |
|
$0.74M |
|
$61.37M |
|
$5.13M |
|
$0.00M |
|
$0.13M |
|
$5.26M |
|
$56.11M |
|
$56.11M |
|
$56.11M |
|
53.74M |
|
| Cash Flow Statement Financials | |
$-29.06M |
|
$-2.19M |
|
$43.88M |
|
$3.02M |
|
$15.65M |
|
$12.62M |
|
$3.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.81 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
|
EBIT Margin |
-- |
-- |
|
-- |
|
-- |
|
$-29.10M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.58% |
|
-15.58% |
|
-14.24% |
|
-15.58% |
|
$1.04 |
|
$-0.62 |
|
$-0.62 |
|